© 2000 - 2012 Virginia Bioinformatics Institute
Wednesday, 16 May 2012
Home
dailypix-image-02-10years.jpg
News and Announcements
Computational modeling yields a novel class of anti-inflammatory drugs
Marketing and Communications - Press Releases
2012, Apr. 19

BLACKSBURG, Va., April 19, 2012 – Researchers in the Nutritional Immunology and Molecular Medicine Laboratory (NIMML) at VBI have recently discovered a new compound that shows promise in ameliorating inflammation in the gut. Congruent to findings last year regarding abscisic acid, the discovery of Lanthionine Synthetase C-like protein 2 (LANCL2) as a novel therapeutic target could aid in relieving such diseases without the side effects of current medications. These findings have been reported in PloS ONE.
read more »
 

Recent News | Complete List

Research Highlight

Josep Bassaganya-Riera

Josep Bassaganya-Riera

Josep Bassaganya-Riera, D.V.M., Ph.D., is a Professor of Immunology at VBI, the Director of the Nutritional Immunology and Molecular Medicine Laboratory and the Center for Modeling Immunity to Enteric Pathogens. His lab conducts translational research aimed at understanding immunoregulatory processes in infectious and autoimmune diseases. He has held and currently holds research grants from various sources including a $10.6M project from the NIH. Dr. Bassaganya-Riera has published over 60 scientific papers, 3 patents and manages a research portfolio of over $12M.

Upcoming Events

No events
read more »